| OFAFX | RMEBX | OFAFX / RMEBX | |
| Total Expense Ratio | 1.17 | 1.07 | 109% |
| Annual Report Gross Expense Ratio | 1.17 | 1.07 | 109% |
| Fund Existence | 26 years | 11 years | - |
| Gain YTD | 4.095 | 14.940 | 27% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 488M | 112B | 0% |
| Annual Yield % from dividends | 1.02 | 1.05 | 97% |
| Returns for 1 year | -7.01 | 6.55 | -107% |
| Returns for 3 years | 7.49 | 30.03 | 25% |
| Returns for 5 years | 9.13 | 53.80 | 17% |
| Returns for 10 years | 26.58 | 92.20 | 29% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FEAC | 28.97 | 0.11 | +0.40% |
| Fidelity Enhanced U.S. All-Cap Equity ETF | |||
| IOPP | 27.31 | N/A | N/A |
| Simplify Tara India Opportunities ETF | |||
| GMAY | 40.82 | -0.01 | -0.03% |
| FT Vest U.S. Eq Mod Buffr ETF - May | |||
| VTES | 101.48 | -0.08 | -0.08% |
| Vanguard Short-Term Tax-Exmpt Bd ETF | |||
| LABD | 26.81 | -0.06 | -0.22% |
| Direxion Daily S&P Biotech Bear 3X ETF | |||